Correlation Between Innova Captab and Akums Drugs
Specify exactly 2 symbols:
By analyzing existing cross correlation between Innova Captab Limited and Akums Drugs and, you can compare the effects of market volatilities on Innova Captab and Akums Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innova Captab with a short position of Akums Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innova Captab and Akums Drugs.
Diversification Opportunities for Innova Captab and Akums Drugs
-0.9 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Innova and Akums is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding Innova Captab Limited and Akums Drugs and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akums Drugs and Innova Captab is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innova Captab Limited are associated (or correlated) with Akums Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akums Drugs has no effect on the direction of Innova Captab i.e., Innova Captab and Akums Drugs go up and down completely randomly.
Pair Corralation between Innova Captab and Akums Drugs
Assuming the 90 days trading horizon Innova Captab Limited is expected to generate 0.92 times more return on investment than Akums Drugs. However, Innova Captab Limited is 1.09 times less risky than Akums Drugs. It trades about 0.29 of its potential returns per unit of risk. Akums Drugs and is currently generating about -0.29 per unit of risk. If you would invest 80,460 in Innova Captab Limited on September 5, 2024 and sell it today you would earn a total of 22,025 from holding Innova Captab Limited or generate 27.37% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Innova Captab Limited vs. Akums Drugs and
Performance |
Timeline |
Innova Captab Limited |
Akums Drugs |
Innova Captab and Akums Drugs Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Innova Captab and Akums Drugs
The main advantage of trading using opposite Innova Captab and Akums Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innova Captab position performs unexpectedly, Akums Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akums Drugs will offset losses from the drop in Akums Drugs' long position.Innova Captab vs. Reliance Industries Limited | Innova Captab vs. Tata Consultancy Services | Innova Captab vs. HDFC Bank Limited | Innova Captab vs. Bharti Airtel Limited |
Akums Drugs vs. Innova Captab Limited | Akums Drugs vs. Industrial Investment Trust | Akums Drugs vs. Edelweiss Financial Services | Akums Drugs vs. Wipro Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |